Yersinia pestis Infection (Plague)

Overview

Yersinia pestis is a gram‑negative bacterium that causes plague, a historically devastating zoonotic disease. Plague occurs in three classic clinical forms—bubonic, septicemic, and pneumonic—each defined by the route of infection and primary symptoms. Although plague is now rare in most industrialized nations, it remains endemic in certain regions of Africa, Asia, and the Americas.

Who it affects: Anyone can be infected, but the highest risk groups are people who live in or travel to endemic rural areas, those who work with wild rodents or domestic animals, and individuals who handle carcasses or fleas without protective measures.

Prevalence: According to the World Health Organization (WHO), there are an average of 2,000–3,000 reported human cases worldwide each year, with ~90 % occurring in Madagascar, the Democratic Republic of Congo, and Peru. The United States reports ~30–40 cases annually, most of them in the southwestern states (Arizona, New Mexico, Colorado) where wildlife reservoirs persist.^{[1] WHO, 2023}

Symptoms

Symptoms vary by clinical form. Below is a complete list with brief descriptions.

Bubonic plague

• Sudden fever and chills – often >38.5 °C (101 °F).
• Tender, swollen lymph nodes (buboes) – usually 1–3 cm, may become necrotic.
• Headache, muscle aches, and fatigue.
• Rapid onset – symptoms typically appear 2–6 days after exposure.

Septicemic plague

• Fever, chills, extreme weakness.
• Abdominal pain, nausea, vomiting.
• Bleeding from gums, nose, or rectum (purpura, petechiae).
• Signs of shock: low blood pressure, rapid heart rate.
• Rapid progression; can lead to death within 24 hours if untreated.

Pneumonic plague

• Fever, chills, severe headache.
• Chest pain and a productive cough that may produce blood‑tinged sputum.
• Shortness of breath, rapid breathing.
• Confusion or mental status changes in severe cases.
• Highly contagious via respiratory droplets.

Other possible manifestations

• Encephalitis (rare) – seizures, altered consciousness.
• Prolonged lymphadenopathy after treatment (post‑plague syndrome).

Causes and Risk Factors

Cause

Plague is caused by Yersinia pestis, which cycles naturally among wild rodents (e.g., ground squirrels, prairie dogs) and their fleas. Humans become infected through:

1. Flea bite – most common for bubonic plague.
2. Direct contact with contaminated animal tissue or fluids (skin abrasions).
3. Inhalation of infected respiratory droplets (primary pneumonic plague).
4. Rarely, ingestion of contaminated food (food‑borne plague).

Risk Factors

• Living or working in endemic rural areas.
• Occupations: wildlife biologists, veterinarians, pest control workers, hunters, and farm laborers.
• Outdoor activities during rodent or flea outbreaks (e.g., camping, hiking).
• Contact with sick or dead animals, especially rodents, rabbits, or domestic cats that hunt rodents.
• Poor housing conditions that allow flea infestations.
• Immunocompromised states (HIV, chemotherapy, uncontrolled diabetes) increase severity.

Diagnosis

Prompt diagnosis is essential because plague can become fatal within hours. Clinicians combine epidemiologic clues with laboratory tests.

Clinical assessment

• History of exposure to endemic areas, rodents, or flea bites.
• Physical findings such as buboes, respiratory distress, or signs of sepsis.

Laboratory tests

1. Direct microscopy – Gram stain of bubo aspirate or sputum may show bipolar “safety‑pin” rods.
2. Culture – Specimens (blood, bubo fluid, sputum, CSF) are inoculated onto selective media (Cefsulodin‑Irgasan‑Novobiocin agar). Growth is confirmed by biochemical tests or MALDI‑TOF.
3. Polymerase chain reaction (PCR) – Rapid detection of Y. pestis DNA from blood, sputum, or lymph node fluid; highly sensitive and specific.
4. Serology – Measurement of anti‑Y. pestis antibodies (IgM/IgG); useful for retrospective diagnosis.
5. Fever panel PCR (multiplex) – Often used in emergency departments to rule out other causes of severe febrile illness.

Imaging

• Chest X‑ray or CT scan for pneumonic plague – may show infiltrates, lobar consolidation, or pleural effusion.
• Ultrasound/CT of abdomen for septicemic plague to assess organ involvement.

Treatment Options

Effective therapy relies on timely administration of appropriate antibiotics and supportive care.

First‑line antibiotics

• Streptomycin 1 g IM/IV every 12 h for 7–10 days (WHO recommendation).
• Gentamicin 5 mg/kg IV/IM once daily for 7–10 days – an alternative where streptomycin is unavailable.
• Fluoroquinolones (e.g., ciprofloxacin 400 mg PO/IV q12h) and doxycycline 100 mg PO/IV q12h are acceptable second‑line agents, especially for patients with aminoglycoside contraindications.^{[2] CDC, 2022}

Adjunctive therapy

• Fluid resuscitation – isotonic crystalloids for septic shock.
• Vasopressors – norepinephrine if hypotension persists.
• Respiratory support – supplemental O₂, non‑invasive ventilation, or intubation for pneumonic plague.
• Anticoagulation – considered if disseminated intravascular coagulation (DIC) develops.

Duration of therapy

Typical courses last 7–10 days for uncomplicated bubonic plague; septicemic and pneumonic forms often require 10–14 days and close monitoring for relapse.

Lifestyle & supportive measures

• Rest and adequate nutrition to aid immune recovery.
• Isolation precautions (droplet‑mask) for patients with pneumonic plague until 48 h after effective antibiotics.

Living with Yersinia pestis infection (plague)

Even after successful treatment, patients may need practical strategies to regain health and prevent transmission.

Recovery Phase

• Follow‑up visits – repeat blood cultures 48 h after starting therapy to confirm clearance.
• Wound care – keep buboes clean; apply sterile dressings; monitor for secondary bacterial infection.
• Gradual activity – start with light activities; avoid heavy lifting for 2–3 weeks.
• Nutrition – high‑protein diet, oral rehydration solutions if gastrointestinal symptoms persist.

Psychological support

Having a historically feared disease can cause anxiety. Seek counseling, join support groups, and discuss concerns with your clinician.

Long‑term monitoring

• Assess for residual lymphadenopathy; most resolve within months, but persistent nodes may need imaging.
• Screen for signs of post‑plague syndrome (fatigue, arthralgia) and treat symptomatically.

Prevention

• Rodent control – keep homes free of food sources, seal entry points, and use traps where appropriate.
• Flea control – apply insecticidal sprays or spot‑on products to pets; treat indoor environments with EPA‑registered flea powders.
• Protective clothing – wear gloves and long sleeves when handling wild animals or carcasses.
• Personal hygiene – wash hands thoroughly after outdoor activities or animal contact.
• Travel precautions – avoid endemic areas during known rodent/flea outbreaks; consult travel clinics for prophylactic advice.
• Vaccination – no licensed human plague vaccine is currently available in the United States, though experimental candidates exist for high‑risk laboratory personnel.

Complications

If untreated or inadequately treated, plague can cause serious, life‑threatening complications:

• Septic shock – multi‑organ failure, high mortality.
• Acute respiratory distress syndrome (ARDS) in pneumonic plague.
• Secondary bacterial infections – e.g., necrotizing pneumonia.
• Gangrene of limbs from vascular thrombosis in septicemic plague.
• Neurologic involvement – meningitis, encephalitis.
• Pregnancy complications – miscarriage or fetal loss.

When to Seek Emergency Care

---

References
[1] World Health Organization. Plague – Fact Sheet. 2023.
[2] Centers for Disease Control and Prevention. Treatment of Plague, 2022.
[3] Mayo Clinic. Plague (Yersinia pestis infection). 2024.
[4] Cleveland Clinic. Plague: Symptoms, Diagnosis, Treatment. 2024.
[5] NIH National Institute of Allergy and Infectious Diseases. Yersinia pestis. 2023.